Australia markets closed

Nascent Biotech, Inc. (NBIO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.04840.0000 (0.00%)
At close: 01:39PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Total revenue
0
0
0
1,000
750
Operating expenses
Research development
100.065
110.975
270.529
197.406
321.938
Selling general and administrative
1,635
1,707
1,502
927.357
1,828
Total operating expenses
2,094
2,230
2,156
1,457
2,150
Operating income or loss
-2,094
-2,230
-2,156
-457.052
-1,400
Interest expense
149.472
385.236
1,723
335.983
336.632
Total other income/expenses net
-
522.168
1,083
473.823
797.644
Income before tax
-1,925
-2,088
-2,801
-470.39
-958.767
Income tax expense
-
0
0
0
0
Income from continuing operations
-1,925
-2,088
-2,801
-470.39
-958.767
Net income
-1,925
-2,088
-2,801
-470.39
-958.767
Net income available to common shareholders
-1,925
-2,088
-2,801
-470.39
-958.767
Basic EPS
-0.02
-0.01
-0.02
-0.00
-0.01
Diluted EPS
-0.02
-0.01
-0.02
-0.00
-0.01
Basic average shares
132,544
155,744
118,569
107,742
72,342
Diluted average shares
132,544
155,744
118,569
107,742
72,342